Raloxifene hydrochloride
- Strength
- 60 mg/1
- Form
- Tablet, Coated
- Class
- Estrogen Agonist/Antagonist
Modavar Pharmaceuticals LLC
Raloxifene hydrochloride
Listed by Eli Lilly and Company
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Estrogen Agonist/Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 0002-4184 |
| FDA application | NDA020815 |
| RxNorm concept | 1490065 |
| Package sizes listed | 1 |
| Marketed since | January 1998 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Modavar Pharmaceuticals LLC
NorthStar Rx LLC
A-S Medication Solutions
AvPAK
Amneal Pharmaceuticals LLC
Glenmark Pharmaceuticals Inc., USA
Exelan Pharmaceuticals, Inc.
Raloxifene
Cipla USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.